Beth Taylor, VP Finance & Chief Accounting Officer at ENDOCYTE INC (ECYT), sold 285 shares at $18.20 ($5K) on 2018-08-20, disclosed to the SEC on 2018-08-22.
Scheduled sale ($5k) by VP Finance & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| NOTV | BUY | 2022-02-22 | $115K | — | Filing → |
| NOTV | BUY | 2021-05-17 | $50K | — | Filing → |
| BASI | BUY | 2021-03-05 | $89K | — | Filing → |